Goodwin Procter advised Cerevel Therapeutics on the deal. Cerevel Therapeutics (Nasdaq: CERE) announced its underwritten public offering of 14,000,000 shares of common stock at a public offering...
Cerevel Therapeutics’ $350 Million Public Offering
TA Associates’ $12.5 Billion Fundraising
Goodwin Procter LLP advised TA Associates on the deal. TA Associates announced its fundraising for TA XIV with total commitments at the hard cap of $12.5 billion....